Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
CFOs On the Move: Week Ending July 1
McDonald’s, Dollar Tree, GoFundMe, Stride, Otis, Intrusion, Monogram Health, Mass Luminosity
By
Lauren Muskett
| July 1, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
vaccines
Risk & Compliance
Senate to Begin Deliberations on Latest COVID-19 Relief Bill
The $1.9 trillion relief bill was passed by the House over the weekend.
By
Lauren Muskett
| March 1, 2021
Read More
The Economy
Retail Sales Fall 1.1% in Largest Pandemic Drop
“The economy will bounce back strongly in [Q2] as vaccine deployment reaches critical mass but until then it’s going to be a long, bleak winter."
By
Matthew Heller
| December 16, 2020
Read More
Risk & Compliance
Early Analysis Shows Pfizer COVID-19 Vaccine 90% Effective
The company said 50 million doses of its two-shot vaccine could be available globally by the end of 2020.
By
Lauren Muskett
| November 9, 2020
Read More
Risk & Compliance
COVID-19 Vaccines Could Generate Over $10B Annual Revenue
Analysts estimate that people will need the vaccine every year, like a flu shot, at a projected cost of $20 per dose.
By
Lauren Muskett
| November 5, 2020
Read More
Strategy
Lilly Buys Vetmedica Pet Vaccines for $885M
The deal will diversify Lilly's Elanco animal medicine business, adding vaccines for rabies and other feline and canine illnesses.
By
Matthew Heller
| October 5, 2016
Read More